www.linkedin.com
Open in
urlscan Pro
2620:1ec:21::14
Public Scan
Submitted URL: https://partners.grail.com/api/mailings/click/PMRGSZBCHI2DKNRQG42SYITVOJWCEORCNB2HI4DTHIXS653XO4XGY2LONNSWI2LOFZRW63JPMNXW2...
Effective URL: https://www.linkedin.com/company/grail-inc.
Submission: On October 16 via api from US — Scanned from DE
Effective URL: https://www.linkedin.com/company/grail-inc.
Submission: On October 16 via api from US — Scanned from DE
Form analysis 2 forms found in the DOM
POST https://www.linkedin.com/uas/login-submit
<form class="google-auth" action="https://www.linkedin.com/uas/login-submit" method="post" aria-hidden="true">
<input name="loginCsrfParam" value="6d888fb3-02f8-42c3-8ad1-4e4c757f57ee" type="hidden">
<input name="session_redirect" value="https://www.linkedin.com/company/grail-inc." type="hidden">
<input name="trk" value="organization_guest_google-one-tap-submit" type="hidden">
<code id="termsAndConditionsRendered" style="display: none"><!--true--></code>
<div class="google-one-tap__module hidden fixed flex flex-col items-center top-[20px] right-[20px] z-[9999]">
<div class="relative top-2 bg-color-background-container-tint pl-2 pr-1 pt-2 pb-3 w-[375px] rounded-md shadow-2xl">
<p class="text-md font-bold text-color-text"> Zustimmen und LinkedIn beitreten </p>
<p class="text-sm text-color-text" data-impression-id="organization_guest_one-tap-skip-tc-text"> Durch Klicken auf „Weiter“ stimmen Sie der
<a href="/legal/user-agreement?trk=organization_guest_google-auth-button_user-agreement" target="_blank" data-tracking-control-name="organization_guest_google-auth-button_user-agreement" data-tracking-will-navigate="true">Nutzervereinbarung</a>,
der
<a href="/legal/privacy-policy?trk=organization_guest_google-auth-button_privacy-policy" target="_blank" data-tracking-control-name="organization_guest_google-auth-button_privacy-policy" data-tracking-will-navigate="true">Datenschutzrichtlinie</a>
und der
<a href="/legal/cookie-policy?trk=organization_guest_google-auth-button_cookie-policy" target="_blank" data-tracking-control-name="organization_guest_google-auth-button_cookie-policy" data-tracking-will-navigate="true">Cookie-Richtlinie</a>
von LinkedIn zu. </p>
</div>
<div data-tracking-control-name="organization_guest_google-one-tap" id="google-one-tap__container"></div>
</div>
<div class="loader loader--full-screen">
<div class="loader__container mb-2 overflow-hidden">
<icon class="loader__icon inline-block loader__icon--default text-color-progress-loading lazy-loaded" data-svg-class-name="loader__icon-svg--large fill-currentColor h-[60px] min-h-[60px] w-[60px] min-w-[60px]" aria-hidden="true"
aria-busy="false"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 60 60" width="60" height="60" focusable="false" class="loader__icon-svg--large fill-currentColor h-[60px] min-h-[60px] w-[60px] min-w-[60px] lazy-loaded"
aria-busy="false">
<g>
<path opacity="1" d="M30.1,16.1L30.1,16.1c-0.6,0-1-0.5-1-1V1c0-0.6,0.5-1,1-1l0,0c0.6,0,1,0.5,1,1v14.1C31.1,15.7,30.6,16.1,30.1,16.1z"></path>
<path opacity="0.85" d="M23.1,18.1L23.1,18.1c-0.5,0.3-1.1,0.1-1.4-0.4L14.5,5.6c-0.3-0.5-0.2-1.1,0.4-1.4l0,0C15.4,3.9,16,4,16.3,4.6l7.2,12.1C23.8,17.2,23.6,17.8,23.1,18.1z"></path>
<path opacity="0.77" d="M17.9,23.1L17.9,23.1c-0.3,0.5-0.9,0.7-1.4,0.4l-12.2-7c-0.5-0.3-0.7-0.9-0.4-1.4l0,0c0.3-0.5,0.9-0.7,1.4-0.4l12.2,7C18,22,18.2,22.7,17.9,23.1z"></path>
<path opacity="0.69" d="M16.1,30.1L16.1,30.1c0,0.6-0.5,1-1,1L1,31.2c-0.6,0-1-0.5-1-1l0,0c0-0.6,0.5-1,1-1l14.1-0.1C15.7,29.1,16.1,29.5,16.1,30.1z"></path>
<path opacity="0.61" d="M18,36.9L18,36.9c0.3,0.5,0.2,1.1-0.4,1.4L5.5,45.6c-0.5,0.3-1.1,0.2-1.4-0.4l0,0c-0.3-0.5-0.2-1.1,0.4-1.4l12.1-7.3C17.1,36.2,17.7,36.4,18,36.9z"></path>
<path opacity="0.53" d="M23.3,42.1L23.3,42.1c0.5,0.3,0.6,0.9,0.4,1.4l-7.3,12.1c-0.3,0.5-0.9,0.6-1.4,0.4l0,0c-0.5-0.3-0.6-0.9-0.4-1.4l7.3-12.1C22.1,41.9,22.8,41.8,23.3,42.1z"></path>
<path opacity="0.45" d="M30.1,43.9L30.1,43.9c0.6,0,1,0.5,1,1V59c0,0.6-0.5,1-1,1l0,0c-0.6,0-1-0.5-1-1V44.9C29,44.4,29.5,43.9,30.1,43.9z"></path>
<path opacity="0.37" d="M37,41.9L37,41.9c0.5-0.3,1.1-0.2,1.4,0.4l7.2,12.1c0.3,0.5,0.2,1.1-0.4,1.4l0,0c-0.5,0.3-1.1,0.2-1.4-0.4l-7.2-12.1C36.4,42.8,36.6,42.2,37,41.9z"></path>
<path opacity="0.29" d="M42.2,36.8L42.2,36.8c0.3-0.5,0.9-0.7,1.4-0.4l12.2,7c0.5,0.3,0.7,0.9,0.4,1.4l0,0c-0.3,0.5-0.9,0.7-1.4,0.4l-12.2-7C42.1,38,41.9,37.4,42.2,36.8z"></path>
<path opacity="0.21 " d="M44,29.9L44,29.9c0-0.6,0.5-1,1-1h14.1c0.6,0,1,0.5,1,1l0,0c0,0.6-0.5,1-1,1L45,31C44.4,31,44,30.5,44,29.9z"></path>
<path opacity="0.13" d="M42.1,23.1L42.1,23.1c-0.3-0.5-0.2-1.1,0.4-1.4l12.1-7.3c0.5-0.3,1.1-0.2,1.4,0.4l0,0c0.3,0.4,0.1,1.1-0.4,1.3l-12.1,7.3C43.1,23.7,42.4,23.6,42.1,23.1z"></path>
<path opacity="0.05" d="M36.9,17.9L36.9,17.9c-0.5-0.3-0.6-0.9-0.4-1.4l7.3-12.1c0.3-0.5,0.9-0.6,1.4-0.4l0,0c0.5,0.3,0.6,0.9,0.4,1.4l-7.4,12.2C38,18.1,37.3,18.2,36.9,17.9z"></path>
<animateTransform attributeName="transform" attributeType="XML" type="rotate" begin="0s" dur="1s" repeatCount="indefinite" calcMode="discrete" keyTimes="0;.0833;.166;.25;.3333;.4166;.5;.5833;.6666;.75;.8333;.9166;1"
values="0,30,30;30,30,30;60,30,30;90,30,30;120,30,30;150,30,30;180,30,30;210,30,30;240,30,30;270,30,30;300,30,30;330,30,30;360,30,30"></animateTransform>
</g>
</svg></icon>
</div>
</div>
</form>POST https://www.linkedin.com/uas/login-submit
<form data-id="sign-in-form" action="https://www.linkedin.com/uas/login-submit" method="post" novalidate="" class="mt-1.5 mb-2">
<input name="loginCsrfParam" value="6d888fb3-02f8-42c3-8ad1-4e4c757f57ee" type="hidden">
<div class="flex flex-col">
<div class="mt-1.5" data-js-module-id="guest-input">
<div class="flex flex-col">
<label class="input-label mb-1" for="organization_guest_contextual-sign-in_sign-in-modal_session_key"> E-Mail-Adresse/Telefon </label>
<div class="text-input flex">
<input class="text-color-text font-sans text-md outline-0 bg-color-transparent grow" autocomplete="username" id="organization_guest_contextual-sign-in_sign-in-modal_session_key" name="session_key" required="" type="text">
</div>
</div>
<p class="input-helper mt-1.5" for="organization_guest_contextual-sign-in_sign-in-modal_session_key" role="alert" data-js-module-id="guest-input__message"></p>
</div>
<div class="mt-1.5" data-js-module-id="guest-input">
<div class="flex flex-col">
<label class="input-label mb-1" for="organization_guest_contextual-sign-in_sign-in-modal_session_password"> Passwort </label>
<div class="text-input flex">
<input class="text-color-text font-sans text-md outline-0 bg-color-transparent grow" autocomplete="current-password" id="organization_guest_contextual-sign-in_sign-in-modal_session_password" name="session_password" required=""
type="password">
<button aria-live="assertive" data-id="sign-in-form__password-visibility-toggle" class="font-sans text-md font-bold text-color-action z-10 ml-[12px] hover:cursor-pointer" aria-label="LinkedIn Passwort einblenden"
data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-password-visibility-toggle-btn" type="button">Einblenden</button>
</div>
</div>
<p class="input-helper mt-1.5" for="organization_guest_contextual-sign-in_sign-in-modal_session_password" role="alert" data-js-module-id="guest-input__message"></p>
</div>
<input name="session_redirect" value="https://www.linkedin.com/company/grail-inc." type="hidden">
<!---->
</div>
<div data-id="sign-in-form__footer" class="flex justify-between
sign-in-form__footer--full-width">
<a data-id="sign-in-form__forgot-password" class="font-sans text-md font-bold link leading-regular
sign-in-form__forgot-password--full-width" href="https://www.linkedin.com/uas/request-password-reset?trk=organization_guest_contextual-sign-in-modal_sign-in-modal_forgot_password" data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_forgot_password" data-tracking-will-navigate="">Passwort vergessen?</a>
<!---->
<input name="trk" value="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-submit" type="hidden">
<button class="btn-md btn-primary flex-shrink-0 cursor-pointer
sign-in-form__submit-btn--full-width w-full max-w-[400px] mx-auto" data-id="sign-in-form__submit-btn" data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-submit-btn" data-tracking-litms=""
type="submit"> Einloggen </button>
</div>
<div class="sign-in-form__divider left-right-divider pt-2 pb-3">
<p class="sign-in-form__divider-text font-sans text-sm text-color-text px-2"> oder </p>
</div>
<input type="hidden" name="controlId" value="d_org_guest_company_overview-organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-submit-btn"><input type="hidden" name="pageInstance"
value="urn:li:page:d_org_guest_company_overview_jsbeacon;wxMuISNaRAuaLT8HeT9FSQ==">
</form>Text Content
LinkedIn und Drittanbieter setzen essenzielle und nicht zwingend erforderliche
Cookies ein, um die LinkedIn Dienste bereitzustellen, zu schützen, zu
analysieren und zu verbessern und um auf LinkedIn und außerhalb von LinkedIn
relevante Anzeigen zu präsentieren (einschließlich zielgruppenspezifischer
Anzeigen und Stellenanzeigen). Weitere Informationen finden Sie in unserer
Cookie-Richtlinie.
Wählen Sie „Akzeptieren“, um dieser Nutzung zuzustimmen, oder wählen Sie
„Ablehnen“, um die nicht zwingend erforderlichen Cookies abzulehnen. Sie können
Ihre Auswahl jederzeit in den Einstellungen aktualisieren.
Akzeptieren Ablehnen
Weiter zum Hauptinhalt
LinkedIn
* Artikel
* Personen
* E-Learning
* Jobs
Mitglied werden Einloggen
GRAIL
BIOTECHNOLOGIEFORSCHUNG
MENLO PARK, CA 76.880 FOLLOWER:INNEN
DETECT CANCER EARLY, WHEN IT CAN BE CURED.
Jobs anzeigen Folgen
*
alle 1.347 Mitarbeiter:innen anzeigen
* Dieses Unternehmen melden
* Übersicht
* Stellen
* Unternehmenskultur
ÜBER UNS
GRAIL is a healthcare company whose mission is to detect cancer early, when it
can be cured. GRAIL is focused on saving lives and improving health by
pioneering new technologies for early cancer detection. The company is using the
power of next-generation sequencing, population-scale clinical studies, and
state-of-the-art computer science and data science to overcome one of medicine’s
greatest challenges with Galleri™, GRAIL’s multi-cancer early detection blood
test. With this proprietary technology, GRAIL is also developing solutions to
help accelerate cancer diagnoses, blood-based detection for minimal residual
disease, and other post-diagnostic applications. GRAIL is headquartered in Menlo
Park, California, with locations in Washington, D.C., North Carolina, and the
United Kingdom. It is supported by leading global investors and pharmaceutical,
technology, and healthcare companies. For more information, please visit
grail.com. Community Guidelines: https://bit.ly/3xigb24
Website http://www.grail.com
Externer Link zu GRAIL
Branche Biotechnologieforschung
Größe 501–1.000 Beschäftigte
Hauptsitz Menlo Park, CA
Art Privatunternehmen
Gegründet 2016
Spezialgebiete Cancer Detection, Cancer Biology, Clinical Trials, Computer
Science, Machine Learning und Data Science
ORTE
* Primär
1525 O'Brien Drive
Menlo Park, CA 94025, US
Wegbeschreibung
BESCHÄFTIGTE VON GRAIL
* SAM AN
* COSMOS NICOLAOU
* BETH GRAHAM, MBA
CHIEF MARKETING OFFICER L HEAD OF DIGITAL MARKETING L HEALTHCARE L VICE
PRESIDENT MARKETING L PATIENT EXPERIENCE L POPULATION HEALTH | BIOTECH |…
* EVA MOK
DIRECTOR OF SOFTWARE ENGINEERING AT GRAIL
Alle Beschäftigten anzeigen
UPDATES
* GRAIL
76.880 Follower:innen
2 Wochen Bearbeitet
* Diesen Beitrag melden
GRAIL has been recognized on Fortune's 2023 #ChangeTheWorld list, as one of
50 companies driving positive social impact. This accomplishment is only
possible due to the steadfast dedication of our employees, who are working
together every day to redefine the status quo of cancer detection. Learn
more: https://bit.ly/3ZB1KDu
*
495 13 Kommentare
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
2 Tage
* Diesen Beitrag melden
The Cancer SIGNAL podcast is one year old! We’ve explored early cancer
detection from a variety of angles: reducing health disparities,
understanding genomics, patient perspectives and more. 🎙️Subscribe or check
out transcripts here: https://bit.ly/3Lx4g6t #MCED
Play Video
Video Player is loading.
Loaded: 7.35%
0:00
PlayBack to start
Stream Type LIVE
Current Time 0:00
/
Duration 0:39
1x
Playback Rate
Show Captions
Mute
Fullscreen
43
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
3 Tage
* Diesen Beitrag melden
Mass Mutual announced their new Health and Wellness Program for eligible
policyowners, which will include multi-cancer early detection. Learn more
below.
MassMutual
113.126 Follower:innen
5 Tage
MassMutual is pleased to announce the launch of our Health and Wellness
Program, which provides tools to eligible policyowners to empower them with
knowledge about their health so they can make informed, proactive health
decisions that can help them lead longer, healthier lives. Learn more.
MASSMUTUAL LAUNCHES INNOVATIVE WELLNESS OFFERINGS THAT HELP POLICYOWNERS
BETTER UNDERSTAND AND PROTECT THEIR HEALTH - MASSMUTUAL
MASSMUTUAL.COM
26 1 Kommentar
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
4 Tage Bearbeitet
* Diesen Beitrag melden
At #HLTH2023, GRAIL's VP of Corporate Affairs, Megan P. Hall, joined a panel
discussion on how novel screening technologies like multi-cancer early
detection can be added to the current standard of care. Learn more about
#MCED: https://bit.ly/45wf8ux
*
*
*
186 3 Kommentare
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
6 Tage Bearbeitet
* Diesen Beitrag melden
Cancer rates among American Indian and Alaska Native individuals have been
found to be 2% higher than among White individuals for incidence, but 18%
higher for mortality. This #IndigenousPeoplesDay hear from Melissa Buffalo,
CEO of the American Indian Cancer Foundation, on what is being done to
address the needs of this population. Listen here: https://bit.ly/46eTqer
*
79
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
1 Woche
* Diesen Beitrag melden
We're excited to share our new partnership with Accarent Health, a leader in
value-based care for oncology. Learn more below.
Accarent Health
485 Follower:innen
2 Wochen
Accarent Health to Offer GRAIL’s Galleri®, a Multi-Cancer Early Detection
Test to its Network and Members. Read the release here:
https://lnkd.in/eHin7i7S
ACCARENT HEALTH TO OFFER GRAIL’S GALLERI®, A MULTI-CANCER EARLY DETECTION
TEST TO ITS NETWORK AND MEMBERS
GLOBENEWSWIRE.COM
94
Gefällt mir Kommentieren Teilen
* GRAIL hat dies direkt geteilt
GRAIL
76.880 Follower:innen
1 Woche Bearbeitet
* Diesen Beitrag melden
The Lancet has just published comprehensive findings from our PATHFINDER
study. The latest results spotlight how adding a multi-cancer early detection
screening test to standard of care screening more than doubled the number of
new cancers detected, with nearly half in early stages. See more insights:
https://bit.ly/3LQpX2H
Play Video
Video Player is loading.
Loaded: 3.00%
0:00
PlayBack to start
Stream Type LIVE
Current Time 0:00
/
Duration 2:30
1x
Playback Rate
Show Captions
Mute
Fullscreen
472 9 Kommentare
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
1 Woche Bearbeitet
* Diesen Beitrag melden
The Lancet has just published comprehensive findings from our PATHFINDER
study. The latest results spotlight how adding a multi-cancer early detection
screening test to standard of care screening more than doubled the number of
new cancers detected, with nearly half in early stages. See more insights:
https://bit.ly/3LQpX2H
Play Video
Video Player is loading.
Loaded: 0.00%
0:00
PlayBack to start
Stream Type LIVE
Current Time 0:00
/
Duration 2:30
1x
Playback Rate
Show Captions
Mute
Fullscreen
472 9 Kommentare
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
1 Woche Bearbeitet
* Diesen Beitrag melden
Our VP of Corporate Affairs and Distinguished Scientist Megan P. Hall is
joining the #HLTH2023 conversation with other industry peers to discuss the
potential benefits of novel early cancer screening technologies. For more
event information and to register to attend or watch online, visit:
https://bit.ly/3LNDAQd
*
67
Gefällt mir Kommentieren Teilen
* GRAIL
76.880 Follower:innen
1 Woche
* Diesen Beitrag melden
This past weekend at #AACRDisp23, our team presented data on multi-cancer
early detection in diverse and medically underserved populations. We
demonstrated that DNA methylation patterns associated with race and ethnicity
do not significantly contribute to classifier performance. We also showed
that implementing a multi-cancer early detection test as an employee benefit
offers an approach to detect cancers for which there is no screening method
and the potential to address socioeconomic disparities in screening.
*
*
137
Gefällt mir Kommentieren Teilen
EINFACH ANMELDEN, DAMIT SIE NICHTS VERPASSEN.
*
Personen von GRAIL finden, die Sie kennen
*
Persönliche Jobempfehlungen erhalten
*
Alle Updates, News und Artikel anzeigen
Jetzt anmelden
VERBUNDENE SEITEN
* GALLERI TEST
Biotechnologieforschung
Menlo Park, California
ÄHNLICHE SEITEN
* ILLUMINA
Biotechnologieforschung
San Diego, CA
* GUARDANT HEALTH
Biotechnologieforschung
Palo Alto, California
* INVITAE
Biotechnologieforschung
San Francisco, CA
* TEMPUS LABS, INC.
Biotechnologieforschung
Chicago, IL
* NATERA
Biotechnologieforschung
Austin, Texas
* EXACT SCIENCES
Biotechnologieforschung
Madison, Wisconsin
* 10X GENOMICS
Biotechnologieforschung
Pleasanton, California
* FREENOME
Biotechnologieforschung
South San Francisco, California
* MYRIAD GENETICS
Biotechnologieforschung
Salt Lake City, Utah
* TWIST BIOSCIENCE
Biotechnologieforschung
South San Francisco, California
Mehr ähnliche Seiten anzeigen Weniger ähnliche Seiten anzeigen
JOBS DURCHSUCHEN
* DIRECTOR-JOBS
1.374.979 freie Stellen
* MANAGER-JOBS
2.003.890 freie Stellen
* MEDICAL SCIENCE LIAISON-JOBS
2.935 freie Stellen
* PROJEKTMANAGER-JOBS
312.603 freie Stellen
* WISSENSCHAFTLER-JOBS
59.545 freie Stellen
* ANALYST-JOBS
760.055 freie Stellen
* IMPLEMENTIERUNGSMANAGER-JOBS
151.864 freie Stellen
* INGENIEUR-JOBS
608.159 freie Stellen
* ACCOUNT-MANAGER-JOBS
152.491 freie Stellen
* VICE PRESIDENT-JOBS
243.153 freie Stellen
* SENIOR-JOBS
1.142.468 freie Stellen
* ENTERPRISE ACCOUNT MANAGER-JOBS
43.227 freie Stellen
* PRÄSIDENT-JOBS
91.996 freie Stellen
* FACHEXPERTE-JOBS
849.142 freie Stellen
* EXECUTIVE-JOBS
700.389 freie Stellen
* RECRUITER-JOBS
321.337 freie Stellen
* BEZIRKSLEITER-JOBS
118.852 freie Stellen
* PRAKTIKANT-JOBS
48.214 freie Stellen
* PARTNER-JOBS
1.094.512 freie Stellen
* BIOINFORMATIKER-JOBS
960 freie Stellen
Weitere ähnliche Jobs anzeigen Weniger ähnliche Jobs anzeigen
FINANZIERUNG
GRAIL Insgesamt 5 Finanzierungsrunden
Letzte Runde
Serie D 6. Juni 2020
Externer Crunchbase-Link für die letzte Finanzierungsrunde
390.000.000,00 USD
Weitere Informationen auf Crunchbase
Weitere Suchen Weitere Suchen
* * Ingenieur-Jobs
* Director-Jobs
* Wissenschaftler-Jobs
* Entwickler-Jobs
* Medical Science Liaison-Jobs
* Manager-Jobs
* Gebietsleiter-Jobs
* Autor-Jobs
* Klinischer Wissenschaftler-Jobs
* Architekt-Jobs
* Leiter der Buchhaltung-Jobs
* Koordinator-Jobs
* Senior-Jobs
* Medizinvertreter-Jobs
* Account-Manager-Jobs
* Business Development-Jobs
* Executive-Jobs
* Wissenschaftlicher Leiter-Jobs
* Recruiter-Jobs
* Analyst-Jobs
* Technischer Redakteur-Jobs
* Projektmanager-Jobs
* Vice President-Jobs
* Fachexperte-Jobs
* Gesundheitsexperte-Jobs
* Klinischer Spezialist-Jobs
* Mobility Manager-Jobs
* Strategischer Account-Manager-Jobs
* Senior Manager:in-Jobs
* Senior Produktmanager-Jobs
* Stellvertretender Direktor Kommunikation-Jobs
* Director Nationale Accounts-Jobs
* Manager Llinische Studien-Jobs
* Stellvertretender Director-Jobs
* Director Unternehmensvertrieb-Jobs
* Event-Manager-Jobs
* Front-End-Entwickler-Jobs
* Implementierungsmanager-Jobs
* Manager Software-QA-Jobs
* Account-Manager Unternehmen-Jobs
* Leiter-Jobs
* Director Business Development-Jobs
* Marketingleiter-Jobs
* Senior Technischer Recruiter-Jobs
* Prozessarchitekt-Jobs
* Mitarbeiter Geschäftsentwicklung-Jobs
* Partner-Jobs
* Salesforce-Administrator-Jobs
* Verkaufsberater-Jobs
* Mitarbeiter in der Qualitätskontrolle-Jobs
* Qualitätsingenieur-Jobs
* Vertreter für medizinische Geräte-Jobs
* Senior Software Entwickler:in-Jobs
* Underwriter-Jobs
* Mitarbeiter Kommunikationsabteilung-Jobs
* Chemieinformatiker-Jobs
* Lehrplanentwickler-Jobs
* Praktikant-Jobs
* Bioinformatiker-Jobs
* Wissenschaftler-Jobs
* LinkedIn © 2023
* Info
* Barrierefreiheit
* Nutzervereinbarung
* Datenschutzrichtlinie
* Cookie-Richtlinie
* Copyright-Richtlinie
* Markenrichtlinine
* Einstellungen für Nichtmitglieder
* Community-Richtlinien
* * العربية (Arabisch)
* Čeština (Tschechisch)
* Dansk (Dänisch)
* Deutsch
* English (Englisch)
* Español (Spanisch)
* Français (Französisch)
* हिंदी (Hindi)
* Bahasa Indonesia (Indonesisch)
* Italiano (Italienisch)
* 日本語 (Japanisch)
* 한국어 (Koreanisch)
* Bahasa Malaysia (Malaysisch)
* Nederlands (Niederländisch)
* Norsk (Norwegisch)
* Polski (Polnisch)
* Português (Portugiesisch)
* Română (Rumänisch)
* Русский (Russisch)
* Svenska (Schwedisch)
* ภาษาไทย (Thai)
* Tagalog (Tagalog)
* Türkçe (Türkisch)
* Українська (Ukrainisch)
* 简体中文 (Chinesisch vereinfacht)
* 正體中文 (Chinesisch traditionell)
Sprache
Zustimmen und LinkedIn beitreten
Durch Klicken auf „Weiter“ stimmen Sie der Nutzervereinbarung, der
Datenschutzrichtlinie und der Cookie-Richtlinie von LinkedIn zu.
Melden Sie sich an, um zu sehen, wen Sie bereits bei GRAIL kennen.
Jetzt anmelden Einloggen
LOGGEN SIE SICH EIN, UM ZU SEHEN, WEN SIE BEREITS BEI GRAIL KENNEN.
Einloggen
SCHÖN, DASS SIE WIEDER DA SIND
E-Mail-Adresse/Telefon
Passwort
Einblenden
Passwort vergessen? Einloggen
oder
Durch Klicken auf „Weiter“ stimmen Sie der Nutzervereinbarung, der
Datenschutzrichtlinie und der Cookie-Richtlinie von LinkedIn zu.
Neu bei LinkedIn? Mitglied werden
oder
Durch Klicken auf „Weiter“ stimmen Sie der Nutzervereinbarung, der
Datenschutzrichtlinie und der Cookie-Richtlinie von LinkedIn zu.
Neu bei LinkedIn? Mitglied werden